Anúncio
Anúncio

SGMT

SGMT logo

Sagimet Biosciences Inc. Series A Common Stock

6.17
USD
Patrocinado
+0.60
+10.83%
09 de jan., 15:59 UTC -5
Encerrado
exchange

Pós-Mercado

6.20

+0.02
+0.37%

Relatórios de Lucros SGMT

Rácio de surpresa positiva

SGMT separação 6 de 10 últimas estimativas.

60%

Próximo Relatório

Data do Próximo Relatório
12 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.43
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/
+7.50%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/
-14.00%

Sagimet Biosciences Inc. Series A Common Stock earnings per share and revenue

On 13 de nov. de 2025, SGMT reported earnings of -0.40 USD per share (EPS) for Q3 25, missing the estimate of -0.39 USD, resulting in a -1.70% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -12.24% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 12 analistas forecast an EPS of -0.43 USD, with revenue projected to reach -- USD, implying an aumentar of 7.50% EPS, and aumentar of 0.00% in Revenue from the last quarter.
FAQ
For Q3 2025, Sagimet Biosciences Inc. Series A Common Stock reported EPS of -$0.40, missing estimates by -1.7%, and revenue of $0.00, 0% as expectations.
The stock price moved down -12.24%, changed from $8.82 before the earnings release to $7.74 the day after.
The next earning report is scheduled for 12 de mar. de 2026.
Based on 12 analistas, Sagimet Biosciences Inc. Series A Common Stock is expected to report EPS of -$0.43 and revenue of -- for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio